Inventor
SPYVEE MARK
US39 patents
⚠️ This page may combine multiple inventors who share the name “SPYVEE MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CV6 THERAPEUTICS NI LTD
13 patentsUS10570098B2Feb 25, 2020
Hydantoin containing deoxyuridine triphosphatase inhibitors
CV6 THERAPEUTICS NI LTD14 citations93
US10562860B2Feb 18, 2020
Hydantoin containing deoxyuridine triphosphatase inhibitors
CV6 THERAPEUTICS NI LTD15 citations93
US10544105B2Jan 28, 2020
Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
CV6 THERAPEUTICS NI LTD14 citations85
US10858344B2Dec 8, 2020
Hydantoin containing deoxyuridine triphosphatase inhibitors
CV6 THERAPEUTICS NI LTD8 citations84
US11104649B2Aug 31, 2021
Hydantoin containing deoxyuridine triphosphatase inhibitors
CV6 THERAPEUTICS NI LTD4 citations83
US10829457B2Nov 10, 2020
Nitrogen ring linked deoxyuridine triphosphatase inhibitors
CV6 THERAPEUTICS NI LTD8 citations83
US11174271B2Nov 16, 2021
6-membered uracil isosteres
CV6 THERAPEUTICS NI LTD4 citations73
US11168059B2Nov 9, 2021
Amino sulfonyl compounds
CV6 THERAPEUTICS NI LTD4 citations73
US12098133B2Sep 24, 2024
Hydantoin containing deoxyuridine triphosphatase inhibitors
CV6 THERAPEUTICS NI LTD1 citations72
US11584723B2Feb 21, 2023
Hydantoin containing deoxyuridine triphosphatase inhibitors
CV6 THERAPEUTICS NI LTD1 citations72
US11124485B2Sep 21, 2021
Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
CV6 THERAPEUTICS NI LTD4 citations72
US11014924B2May 25, 2021
Hydantoin containing deoxyuridine triphosphatase inhibitors
CV6 THERAPEUTICS NI LTD4 citations72
US11518746B2Dec 6, 2022
Nitrogen ring linked deoxyuridine triphosphatase inhibitors
CV6 THERAPEUTICS NI LTD0 citations62
EISAI CO LTD
8 patentsUS7528152B2May 5, 2009
Hemiasterlin derivatives and uses thereof in the treatment of cancer
EISAI CO LTD19 citations92
US7192972B2Mar 20, 2007
Hemiasterlin derivatives and uses thereof
EISAI CO LTD18 citations92
US7799827B2Sep 21, 2010
Macrocyclic compounds useful as pharmaceuticals
EISAI CO LTD16 citations91
US7064211B2Jun 20, 2006
Hemiasterlin derivatives and uses thereof
EISAI CO LTD28 citations91
US7202234B2Apr 10, 2007
Compounds and methods for treating Toll-like receptor 2-related diseases and conditions
EISAI CO LTD18 citations90
US7585976B2Sep 8, 2009
Hemiasterlin derivatives and uses thereof
EISAI CO LTD13 citations83
US7915306B2Mar 29, 2011
Macrocyclic compounds useful as pharmaceuticals
EISAI CO LTD13 citations82
US7314936B2Jan 1, 2008
Deazapurines and uses thereof
EISAI CO LTD8 citations71
EISAI R&D MAN CO LTD
8 patentsUS8354400B2Jan 15, 2013
Benzoxazole compounds and methods of use
EISAI R&D MAN CO LTD29 citations91
US7550501B2Jun 23, 2009
Compounds and methods for treating toll-like receptor 2-related diseases and conditions
EISAI R&D MAN CO LTD18 citations90
US8686018B2Apr 1, 2014
Pharmaceutical composition
EISAI R&D MAN CO LTD5 citations81
US7666875B2Feb 23, 2010
Hydantoin compounds
EISAI R&D MAN CO LTD11 citations81
US9000024B2Apr 7, 2015
Pharmaceutical composition
EISAI R&D MAN CO LTD4 citations70
US7868002B2Jan 11, 2011
Deazapurines and uses thereof
EISAI R&D MAN CO LTD0 citations50
US7838548B2Nov 23, 2010
Compounds and methods for treating toll-like receptor 2-related diseases and conditions
EISAI R&D MAN CO LTD1 citations50
US7985746B2Jul 26, 2011
Imidazoazepinone compounds
EISAI R&D MAN CO LTD1 citations47
UNIV SOUTHERN CALIFORNIA
4 patentsUS10577321B2Mar 3, 2020
Deoxyuridine triphosphatase inhibitors
UNIV SOUTHERN CALIFORNIA15 citations85
US10570100B2Feb 25, 2020
Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
UNIV SOUTHERN CALIFORNIA14 citations85
US11198677B2Dec 14, 2021
Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
UNIV SOUTHERN CALIFORNIA4 citations72
US11479531B2Oct 25, 2022
Deoxyuridine triphosphatase inhibitors
UNIV SOUTHERN CALIFORNIA0 citations62